title: Increased expression of Wnt5a in psoriatic plaques.
abstract: Psoriasis vulgaris is characterized by hyperproliferation and incomplete terminal differentiation of epidermal keratinocytes. Despite the established role of Wnt pathways in the regulation of stem cell proliferation and differentiation, they have not yet been associated with the pathophysiology of psoriasis. Here, we took biopsies from uninvolved and from lesional skin of 20 patients with plaque-type psoriasis. The biopsies were used for microarray RNA expression profiling. Based on paired samples from 13 patients, we defined 179 genes that were more than 2-fold differentially expressed in lesional skin. This list included 16 genes with known or possible association to the canonical Wnt/beta-catenin or the non-canonical Wnt/Ca2+ pathway. The expression of Wnt5a was 4-fold higher in lesional skin. Other Wnt molecules were largely unchanged (Wnt4 and Wnt16), or tended to be expressed at lower levels (Wnt7b). The mRNA expression levels of two inhibitory factors related to Wnt signaling, frizzled-related protein, and dickkopf homolog 2, were reduced in lesional skin, as was mRNA expression of cyclin D1. These findings were confirmed by quantitative reverse transcription-PCR experiments. We conclude that Wnt5a and other Wnt pathway genes are differentially expressed in psoriatic plaques. Their functional contribution to the pathophysiology of psoriasis needs to be elaborated.
authors.affiliation: Schering AG Berlin, Global Pharmacogenomics, Biomarker Development and Non-Clinical Statistics, Berlin, Germany. joachim.reischl@schering.de
authors.forename: Joachim
authors.initials: J
authors.lastname: Reischl
authors.forename: Susanne
authors.initials: S
authors.lastname: Schwenke
authors.forename: Johanna M
authors.initials: JM
authors.lastname: Beekman
authors.forename: Ulrich
authors.initials: U
authors.lastname: Mrowietz
authors.forename: Steffen
authors.initials: S
authors.lastname: Stürzebecher
authors.forename: Jürgen F
authors.initials: JF
authors.lastname: Heubach
mesh_terms: D001706:Biopsy; D002118:Calcium / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D007249:Inflammation / Q000209:etiology; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000235:genetics; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000502:physiology; D011565:Psoriasis / Q000209:etiology / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D012867:Skin / Q000378:metabolism; D051153:Wnt Proteins / Q000235:genetics* / Q000502:physiology; D000071818:Wnt-5a Protein; D051176:beta Catenin / Q000502:physiology
chemical_list: D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011518:Proto-Oncogene Proteins; C085389:WNT5A protein, human; D051153:Wnt Proteins; D000071818:Wnt-5a Protein; D051176:beta Catenin; D002118:Calcium